FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On April 21, 2005
Docket # Title
1979N-0113 Parenteral Multivitamin Products
2004D-0041 Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Content of Labeling
2004D-0410 Application User Fees for Combination Products
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
2004N-0463 Food Labeling: Prominence of Calories
2004N-0469 Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records
2004N-0470 Agency Information Collection Activities: Proposed Collection; Comment Request;
2004N-0486 Agency Information Collection Activities: Proposed Collection; Comment Request; Experimental Study of Health Claims on Food Packages
2005D-0122 Guidance for Industry on Exploratory IND Studies
2005D-0133 Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection
2005N-0059 Withdrawal of Approval of a New Animal Drug Application; Dichlorophene and Toluene Capsules
2005N-0119 Preparation for the International Conference on Harmonization Meetings in Brussels, Belgium: Public Meeting
2005N-0123 Agency Information Collection Activities; Proposed Collection; Comment Request; Survey of Need for Online Medical Device Information
2005N-0137 Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
1979N-0113 Parenteral Multivitamin Products
N 5 FDA Vol #: 5
2004D-0041 Guidance for Industry on Providing Regulatory Submissions in Electronic Format--Content of Labeling
GDL 2 Guideline Vol #: 1
NAD 2 FDA Vol #: 1
2004D-0410 Application User Fees for Combination Products
GDL 2 Guideline Vol #: 1
NAD 1 FDA Vol #: 1
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
C 20 O. T. Marchant Vol #: 1
C 21 J. I. Appel Vol #: 1
C 22 T. Hammer Vol #: 1
C 23 K. Olson Vol #: 1
C 24 I. G. Buirrhatter Vol #: 1
C 25 D. Douglass Vol #: 4
C 26 M. S. Patterson Vol #: 1
C 27 D. A. Maller Vol #: 1
C 28 J. C. Groen Vol #: 1
C 29 T. M. Miller Vol #: 1
C 30 S. A. Roman Vol #: 1
C 31 W. Mrohs Vol #: 1
C 32 M. Hutton Vol #: 1
C 33 E. Merrill Vol #: 1
C 34 David Stinson Vol #: 1
C 35 A.L. Lindeman Vol #: 1
C 36
Tab A, Tab B, Tab C
Regulations Policy and Managemnt Staff Vol #: 1
EMC 536 L.Golan Vol #: 4
EMC 537 unsign Vol #: 4
EMC 538 S. Turkfeld Vol #: 4
EMC 539 unsign Vol #: 4
EMC 540 A. Downs Vol #: 4
EMC 541 unsign Vol #: 4
EMC 542 M. Hinze Vol #: 4
EMC 543 unsign Vol #: 4
EMC 544 S. Hessler Vol #: 4
EMC 545 S. Siegel Vol #: 4
EMC 546 L. Henigin Vol #: 4
EMC 547 M. Bramble Vol #: 4
EMC 548 E. Mudra Vol #: 4
EMC 549 A. Jompole Vol #: 4
EMC 550 Club Industry's Fitness Business Pro Vol #: 4
EMC 551 S. Cofield Vol #: 4
EMC 552 K. Leapley Vol #: 4
EMC 553 T. Yahiel Vol #: 4
EMC 554 S. Macomber Vol #: 4
EMC 555 M. Little Vol #: 4
EMC 556 R. Trinemeyer Vol #: 4
EMC 557 J. Taylor Vol #: 4
EMC 558 N. Miano Vol #: 4
EMC 559 J. W. Matsuno Vol #: 4
EMC 560 D. Lent Vol #: 4
EMC 561 J. Basehart Vol #: 4
EMC 562 K. Frank Vol #: 4
EMC 563 K. L. Martin Vol #: 4
EMC 564 M. Waid Vol #: 4
EMC 565 J. Lee Vol #: 4
EMC 566 A. K. Herndon Vol #: 4
EMC 567 L. B. Terry Vol #: 4
EMC 568 K. Cramer Vol #: 4
EMC 569 J. Saunders Vol #: 4
EMC 570 J. O. Whitaker Vol #: 4
EMC 571 J. Johnson Vol #: 4
EMC 572 A. Dodd Vol #: 4
EMC 573 C. S. Newman Vol #: 4
EMC 574 P. H. Earnest Vol #: 4
EMC 575 D. Zenger Vol #: 4
EMC 576 J. C. Gehrke Vol #: 4
EMC 577 N. Winkler Vol #: 4
EMC 578 A. Schepers Vol #: 4
EMC 579 K. Adams Vol #: 4
EMC 580 G. Young Vol #: 4
EMC 581 M. Tegtmier Vol #: 4
EMC 582 unsign Vol #: 4
EMC 583 M. Imposimato Vol #: 4
EMC 584 C. Felder Vol #: 4
EMC 585 M. Pedersen Vol #: 4
EMC 586 K. A. Eickman Vol #: 4
EMC 587 L. A. Bryan Vol #: 4
EMC 588 T. Williams Vol #: 4
EMC 589 Clinical Maine Medical Center Vol #: 4
EMC 590 M. Kirincic Vol #: 4
EMC 591 Tania Widish Vol #: 4
2004N-0463 Food Labeling: Prominence of Calories
EMC 192 no signature Vol #: 3
EMC 193 R. Broussard Vol #: 3
EMC 194 K. Fedorko Vol #: 3
EMC 195 J. Barnes Vol #: 3
EMC 196 A. & M Hamerstone Vol #: 3
EMC 197 A. Burrows Vol #: 3
EMC 198 J. Yang Vol #: 3
EMC 199 J. Yang Vol #: 3
EMC 200 V. R. Harris Vol #: 3
EMC 201 V. R. Harris Vol #: 3
EMC 202 P. Barnes Vol #: 3
EMC 203 J. Nugent Vol #: 3
EMC 204 Brandt Custom Homes, Inc. Vol #: 3
EMC 205 M. and L. Castner Vol #: 3
EMC 206 Pacific Coast Producers Vol #: 3
EMC 207 B. Weil Vol #: 3
EMC 208 A. Chisari Vol #: 3
EMC 209 no signature Vol #: 3
EMC 210 C. Ramstedt Vol #: 3
EMC 211 D. Paul Vol #: 3
EMC 212 M. Baron Vol #: 3
EMC 213 M. Baron Vol #: 3
EMC 214 A. Milstead Vol #: 3
EMC 215 no signature Vol #: 3
EMC 216 C. Furnberg Vol #: 3
EMC 217 B Orasco Vol #: 3
EMC 218 I. Buratti Vol #: 3
EMC 219 J. Evans Vol #: 3
EMC 220 B. Bailes Vol #: 3
EMC 221 B. Elsner Vol #: 3
EMC 222 J. Woelflein Vol #: 3
EMC 223 J. Wiley Matsuno Vol #: 3
EMC 224 B. Sachau Vol #: 3
EMC 225 J. Leigh Botjer Vol #: 3
EMC 226 K. Cramer Vol #: 3
EMC 227 J. Johnson Vol #: 3
EMC 228 C. Newman Vol #: 3
EMC 229 P. H. Earnest Vol #: 3
EMC 230 J. Vlodek Berren Vol #: 3
2004N-0469 Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General Records
N 2 FDA Vol #: 1
2004N-0470 Agency Information Collection Activities: Proposed Collection; Comment Request;
N 2 FDA Vol #: 1
2004N-0486 Agency Information Collection Activities: Proposed Collection; Comment Request; Experimental Study of Health Claims on Food Packages
N 2 FDA Vol #: 1
2005D-0122 Guidance for Industry on Exploratory IND Studies
GDL 1 Guideline Vol #: 1
NAD 1 FDA Vol #: 1
2005D-0133 Guidance for Industry: Assessing Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection
BKG 1 Refs 1 -13 found in 70FR20575 Vol #: 2
GDL 1 Guideline Vol #: 1
NAD 1 FDA Vol #: 1
2005N-0059 Withdrawal of Approval of a New Animal Drug Application; Dichlorophene and Toluene Capsules
LET 1 HFA-305 to Natchez Animal Supply Co Vol #: 1
2005N-0119 Preparation for the International Conference on Harmonization Meetings in Brussels, Belgium: Public Meeting
NM 1 FDA Vol #: 1
2005N-0123 Agency Information Collection Activities; Proposed Collection; Comment Request; Survey of Need for Online Medical Device Information
N 1 FDA Vol #: 1
2005N-0137 Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
NM 1 FDA Vol #: 1

Page created on May 3, 2005 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management